Related Experiment Video
Updated: May 31, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Systemic capillary leak syndrome
Aline Lopes Bressan1, Alexandre Gripp, Elisa Fontenelle de Oliveira
1Dermatology service from the Pedro Ernesto University Hospital - Rio de Janeiro (RJ), Brazil. alinebressan@ig.com.br
Anais Brasileiros De Dermatologia
|July 9, 2011
Summary
Systemic capillary leak syndrome, a rare condition of increased capillary permeability, is primarily linked to unstable psoriasis in dermatology. This review highlights its potentially fatal nature and current therapeutic approaches.
Area of Science:
- Dermatology
- Internal Medicine
- Pathophysiology
Background:
- Systemic capillary leak syndrome (SCLS) is a rare disorder characterized by recurrent episodes of increased systemic capillary permeability.
- This leads to a rapid shift of plasma volume from the intravascular to the extravascular space, causing hypotension and organ hypoperfusion.
- While various triggers exist, unstable psoriasis is a notable etiology within dermatology.
Purpose of the Study:
- To present systemic capillary leak syndrome (SCLS) as a potentially fatal condition encountered in dermatological practice.
- To underscore the association between unstable psoriasis and SCLS.
- To review current and emerging treatment strategies for SCLS.
Main Methods:
- Literature review focusing on SCLS associated with dermatological conditions, particularly psoriasis.
- Analysis of case reports and clinical data from the Department of Dermatology.
- Synthesis of information on pathophysiology, clinical presentation, and therapeutic interventions.
Main Results:
- Unstable psoriasis is identified as a significant, though uncommon, cause of SCLS in a dermatology setting.
- Current treatments for SCLS involve intravenous immunoglobulin, corticosteroids, and supportive care.
- Numerous therapeutic agents are under investigation for SCLS management.
Conclusions:
- Systemic capillary leak syndrome (SCLS) represents a critical medical condition that dermatologists must recognize.
- Early diagnosis and appropriate management are crucial for improving outcomes in SCLS patients.
- Further research is warranted to optimize SCLS treatment protocols, especially in the context of dermatological comorbidities.
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:19Ascites
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...